Latest Earnings Results: Q2 '26
Estimated EPS
$1.48
Reported EPS
$1.55
Surprise
+4.76%
Estimated Rev
$1.57B
Reported Rev
$1.6B
Surprise
+1.66%
• Reported GAAP EPS of $1.55 up 9.15% YoY • Reported revenue of $1.6B up 9.58% YoY • Encompass Health increased its full-year 2026 guidance, now projecting net operating revenue of $6.41B to $6.49B, Adjusted EBITDA of $1.365B to $1.395B, and adjusted earnings per share of $6.02 to $6.25.
Bullish Takeaway
Encompass Health delivered strong financial performance with revenue and EBITDA growth, driven by increased patient volumes and a disciplined strategy of expanding hospital capacity and access to rehabilitative care services.
Bearish Takeaway
Encompass Health reported increased operating expenses and a decline in adjusted free cash flow, while facing ongoing structural risks related to labor shortages and potential changes in government reimbursement programs.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | $1.48 | $1.55 | 4.76% | BEAT |
Q1 '26 | $1.49 | $1.60 | 7.09% | BEAT |
Q4 '25 | $1.30 | $1.46 | 12.14% | BEAT |
Q3 '25 | $1.19 | $1.23 | 2.97% | BEAT |
Q2 '25 | $1.23 | $1.40 | 14.13% | BEAT |